Viridian Therapeutics, Inc.
VRDNNASDAQ
USReal-Time Price
USReal-Time Price$22.88USD
-0.14 (-0.59%)Today
BTI Score
BASIC required or higher
View pricingBTI Fair Market Cap
$1.42B
Revenue-based (growth phase)
Biotechnology
Hold
Viridian Therapeutics, Inc. (VRDN) Key Statistics
All Viridian Therapeutics, Inc. (VRDN) key statistics in one place: market cap, valuation multiples, profitability, growth and risk metrics.
Valuation Measures
Market Cap$2.59B
Enterprise Value$2.67B
Trailing P/E—
Forward P/E—
PEG Ratio—
Price / Sales (TTM)—
Price / Book—
EV / Revenue37.53
EV / EBITDA—
Financial Highlights
Fiscal Year End—
Most Recent Quarter—
Profit Margin—
Operating Margin—
Return on Assets—
Return on Equity—
Quarterly Rev. Growth—
Gross Profit—
EBITDA—
Net Income—
Diluted EPS$-3.53
Total Cash—
Total Debt—
Free Cash Flow—
Trading Information
Beta (5Y Monthly)1.11
52-Week Change—
S&P 500 52-Wk Change—
52-Week High$34.29
52-Week Low$13.18
50-Day MA—
200-Day MA—
Avg. Volume1.97M
Shares Outstanding875.2M
Float815.4M
Short % of Float—
Short Ratio—